These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15789133)

  • 41. A review of intrathecal baclofen in the management of spasticity.
    Porter B
    Br J Nurs; 1997 Mar 13-26; 6(5):253-60, 262. PubMed ID: 9155275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of botulinum toxin and intrathecal baclofen in hip dysplasia in cerebral palsy.
    Gormley M
    Dev Med Child Neurol; 2023 Aug; 65(8):1125. PubMed ID: 37208907
    [No Abstract]   [Full Text] [Related]  

  • 43. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
    Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R
    Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posterior cervical approach for intrathecal baclofen pump insertion in children with previous spinal fusions. Technical note.
    Liu JK; Walker ML
    J Neurosurg; 2005 Jan; 102(1 Suppl):119-22. PubMed ID: 16206746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical treatment of spasticity.
    Delaney JF
    Curr Probl Surg; 1980 Apr; 17(4):245-8. PubMed ID: 6892798
    [No Abstract]   [Full Text] [Related]  

  • 46. Intrathecal baclofen for spasticity management in Rett syndrome.
    Kadyan V; Clairmont AC; George RJ; Johnson EW
    Am J Phys Med Rehabil; 2003 Jul; 82(7):560-2. PubMed ID: 12819544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
    Albright AL; Gilmartin R; Swift D; Krach LE; Ivanhoe CB; McLaughlin JF
    J Neurosurg; 2003 Feb; 98(2):291-5. PubMed ID: 12593613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].
    Jóźwiak M; Idzior M; Huber J; Szulc A; Grottel K
    Chir Narzadow Ruchu Ortop Pol; 2003; 68(4):253-9. PubMed ID: 14702678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology.
    Latash ML; Penn RD
    Physiother Res Int; 1996; 1(4):229-46. PubMed ID: 9238740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrathecal baclofen therapy does not prevent hip displacement in children with cerebral palsy.
    Howard JJ; Shrader MW
    Dev Med Child Neurol; 2023 Aug; 65(8):1124. PubMed ID: 37208917
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug treatments for spasticity.
    Yelnik AP; Simon O; Bensmail D; Chaleat-Valayer E; Decq P; Dehail P; Quentin V; Marque P; Parratte B; Pellas F; Rousseaux M; Trocello JM; Uzzan M; Dumarcet N;
    Ann Phys Rehabil Med; 2009 Dec; 52(10):746-56. PubMed ID: 19892619
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of spasticity with the intrathecal administration of baclofen].
    Lazorthes Y; Sallerin B; Verdié JC; Casaux J; Caraoué F; Sol JC
    Neurochirurgie; 1998 Sep; 44(3):201-8. PubMed ID: 9827437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity.
    Sadiq SA; Poopatana CA
    J Neurol; 2007 Oct; 254(10):1464-5. PubMed ID: 17932702
    [No Abstract]   [Full Text] [Related]  

  • 55. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
    Baker KW; Tann B; Mutlu A; Gaebler-Spira D
    J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral motor, communication, and nutritional status of children during intrathecal baclofen therapy: a descriptive pilot study.
    Bjornson KF; McLaughlin JF; Loeser JD; Nowak-Cooperman KM; Russel M; Bader KA; Desmond SA
    Arch Phys Med Rehabil; 2003 Apr; 84(4):500-6. PubMed ID: 12690587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis.
    Marquardt G; Seifert V
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):275-6. PubMed ID: 11796788
    [No Abstract]   [Full Text] [Related]  

  • 58. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacology of spasticity. Does therapy remain in deep sleep?].
    Noth J
    Nervenarzt; 2000 Dec; 71(12):927-8. PubMed ID: 11139987
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter to the Editor: Ascenda catheter versus silicone catheter in intrathecal baclofen therapy.
    Draulans N; Theys T; Nuttin B; Kiekens C
    J Neurosurg Pediatr; 2017 Feb; 19(2):269-270. PubMed ID: 27885944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.